Kalind Fund Raise of ₹624 Cr

Kalind Board Meeting Date

Kalind Ltd will hold a Board meeting on 31 October 2026 to update on and decide the ongoing preferential issue of 8,60,86,956 equity shares. In-principle approval from BSE is still awaited.

Kalind Other Announcement

Kalind Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI LODR Regulations.

Kalind Annual General Meeting

Kalind Limited held its Annual General Meeting on September 29, 2026, passing resolutions including financial statement adoption and preferential share issuance.

Kalind Annual General Meeting

Kalind Limited issued a corrigendum to its 32nd AGM notice, withdrawing a previously proposed warrant issue. It replaced this with a new preferential equity issue.

Value

₹99.00 Cr

Kalind Capital Structure Change

Kalind Limited's board approved a fresh preferential issue of 8.61 crore equity shares at ₹11.50 per share, raising ₹99 Crore, replacing a prior warrant proposal.

Value

₹99.00 Cr

Kalind Board Meeting Date

Kalind Limited scheduled a board meeting for September 17, 2026, to reconsider and potentially amend previously approved fund-raising proposals.

Sudarshan Pharma Industries Fund Raise of ₹72 Cr

Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.

Value

₹72.00 Cr

Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr

Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.

Value

₹68.20 Cr

Kanel Industries Fund Raise of ₹16.99 Cr

Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.

Value

₹16.99 Cr

Execution

Rights issue opens 23 November 2026 and closes 30 November 2026

Sudarshan Pharma Industries Fund Raise

Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.

GAIL (India) Fund Raise

GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.

Gujarat Inject (Kerala) Fund Raise of ₹3 Cr

Gujarat Inject Kerala's board approved a Rs.3 Crore preferential warrant issue to public investors. Authorised capital will rise to Rs.17.63 Crore, subject to shareholder approval.

Value

₹3.00 Cr